Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)

China · Delayed Price · Currency is CNY

16.59

+0.15 (0.91%)

At close: Aug 3, 2026

-18.28% (1Y)

Market Cap	13.69B -19.9%
Revenue (ttm)	4.20B +1.3%
Net Income	462.64M +9.5%
EPS	0.55 +10.2%
Shares Out	832.47M
PE Ratio	29.78
Forward PE	26.10
Dividend	0.26 (1.58%)
Ex-Dividend Date	Jul 3, 2026

Volume	3,464,555
Open	16.44
Previous Close	16.44
Day's Range	16.36 - 16.59
52-Week Range	14.46 - 22.95
Beta	0.48
Analysts	Strong Buy
Price Target	24.19 (+45.81%)
Earnings Date	Aug 28, 2026

About Huaxia Eye Hospital Group

Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis, treatment, and other ophthalmic medical services for patients with eye disease and myopia; prevention and intervention work to the public. It offers services in the areas of cataract, refractive errors, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular surface, glaucoma, orbital and ocular tumors, optometry, and ocular trauma, as well as engages in community services. The com... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1997

Employees 8,200

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301267

Full Company Profile

Financial Performance

In 2025, Huaxia Eye Hospital Group's revenue was 4.14 billion, an increase of 2.78% compared to the previous year's 4.03 billion. Earnings were 440.65 million, an increase of 2.80%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 301267 stock is "Strong Buy." The 12-month stock price target is ¥24.19, which is an increase of 45.81% from the latest price.

Price Target

¥24.19

(45.81% upside)

Analyst Consensus: Strong Buy

Stock Forecasts